The AVITHRAPID consortium "Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases" is part of the Horizon Europe Framework Programme and consists of 18 participants and partners from 8 countries.
Project
Description
Outcome &
Deliverables
Research
Repositories
Latest News & Events from AVITHRAPID
AVITHRAPID at INF-ACT Conference
The partners of AVITHRAPID strive to disseminate project activities during key scientific events, both at local and international level. High-profile conferences are pivotal opportunities to meet academia and industries and confront with state-of-the-art research in AVITHRAPID-related topics. This INF-ACT conference, held in
AVITHRAPID project meets HERA
On 3 March 2025, the AVITHRAPID consortium met HERA during the first AVITHRAPID seminar to foster collaboration and explore new opportunities in the domain of antivirals as response against pandemic infectious diseases. During the online meeting, Prof. Bjoern Windshuegel and Prof. Vincenzo
AVITHRAPID Launches ‘AVITHRAPID SEMINARS’ to Advance Pandemic Preparedness and Antiviral Research
AVITHRAPID, the cutting-edge European initiative dedicated to accelerating antiviral research and pandemic preparedness, is proud to announce the launch of AVITHRAPID SEMINARS—a dynamic series of expert-driven discussions uniting regulatory authorities, pharmaceutical industry leaders, European projects, and key stakeholders. The first closed-door seminar